跳转至内容
Merck

GF88506782

tube, 100mm, outside diameter 0.40mm, inside diameter 0.16mm, wall thickness 0.12mm, as drawn, 99.95%

别名:

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
Pt
CAS号:
分子量:
195.08
MDL號碼:
分類程式碼代碼:
12141734
PubChem物質ID:
NACRES:
NA.23

化驗

≥99.95%

形狀

tubes

製造商/商標名

Goodfellow 885-067-82

電阻係數

10.6 μΩ-cm, 20°C

bp

3827 °C (lit.)

mp

1772 °C (lit.)

密度

21.45 g/cm3 (lit.)

SMILES 字串

[Pt]

InChI

1S/Pt

InChI 密鑰

BASFCYQUMIYNBI-UHFFFAOYSA-N

一般說明

For updated SDS information please visit www.goodfellow.com.

法律資訊

Product of Goodfellow

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

nwg

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Josep Ramon Germà-Lluch et al.
Archivos espanoles de urologia, 66(5), 524-535 (2013-06-26)
Cisplatin has been the cornerstone of germ cell testicular tumors therapy since its introduction more tan 30 years ago, and a basic part of the schemes given to multiple ovarian, lung, head and neck, and bladder tumors among others. Some
Xiao-yong Shen et al.
PloS one, 8(8), e69553-e69553 (2013-08-14)
X-ray repair cross-complementing protein 3 (XRCC3) is an essential gene involved in the double-strand break repair pathway. Published evidence has shown controversial results about the relationship between XRCC3 Thr241Met polymorphism and clinical outcomes of non-small cell lung cancer (NSCLC) patients
A G Quiroga
Journal of inorganic biochemistry, 114, 106-112 (2012-07-24)
This focused review is devoted to our advances in developing trans platinum complexes as antitumoral complexes, in particular those bearing aliphatic amines. It includes some fundamental aspects of the understanding of non conventional metallodrug mechanism. The perspective is arranged by
Xiaoyong Wang et al.
Chemical Society reviews, 42(1), 202-224 (2012-10-09)
Platinum-based anticancer drugs occupy a crucial role in the treatment of various malignant tumours. However, the efficacy and applicability of platinum drugs are heavily restricted by severe systemic toxicities and drug resistance. Different drug targeting and delivery (DTD) strategies have
Jianbo Wu et al.
Accounts of chemical research, 46(8), 1848-1857 (2013-07-03)
An efficient oxygen reduction reaction (ORR) offers the potential for clean energy generation in low-temperature, proton-exchange membrane fuel cells running on hydrogen fuel and air. In the past several years, researchers have developed high-performance electrocatalysts for the ORR to address

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门